FDA Clearance Tracker · K251849
StaClear Syringe (SC250AN); StaClear Syringe (SC250LS); StaClear Syringe (SC250LL)
Last checked: Nov 20, 2026Latest source record: Nov 21, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Nov 21, 2025
Substantially Equivalent
Time to decision
158 days
Received Jun 16, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K251849
- Device name
- StaClear Syringe (SC250AN); StaClear Syringe (SC250LS); StaClear Syringe (SC250LL)
- Applicant
- Staclear, Inc.
- Applicant location
- Raleigh, NC
- Received
- Jun 16, 2025
- Decided
- Nov 21, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Ophthalmic Syringe (QLY)
- Device class
- Class II
- Regulation
- 21 CFR 880.5860
- Specialty
- Hospital Medicine & Nursing
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QLY. The earliest in FDA's data is K200242, decided Jul 27, 2020.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K251849
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Staclear, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K243936 · Decided Apr 3, 2025 · 104 days after receipt
Device type: Ophthalmic Syringe (QLY) · Hospital Medicine & Nursing
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.